The British Pharmacopoeia (BP) recently launched a public consultation to understand users views on the application of Quality by Design principles to analytical procedures (AQbD) in the pharmacopoeia, which will close 31st August 2019. This consultation includes a technical report which provides a review of the project, while introducing initial key outcomes and conclusions. On the 16th August experts from BP will host a webinar for ABPI members on current BP initiatives, with a presentation and then a Q&A session.
James Pound, Group Manager, British Pharmacopoeia & Laboratory Services
Peter Crowley, Principal Pharmacopoeial Scientist – Product Portfolio Co-ordinator, British Pharmacopoeia Secretariat
Alistair Gibb, Editor-in-chief of the British Pharmacopoeia
Friday 16 August 2019
13:15 - 14:00